CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Berger Dietmar Chief Medical Officer | Option exercise | +16,326 | 16,326 | ||
| 2026-01-02 | Berger Dietmar Chief Medical Officer | Shares withheld for taxes | −6,944 | $121.60 | $844K | 9,382 |
| 2026-01-02 | Berger Dietmar Chief Medical Officer | Option exercise · Restricted Stock Unit | −16,326 | 41,179 | ||
| 2025-12-29 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −10,000 | $124.83 | $1.2M | 566,698 |
| 2025-12-15 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −3,000 | $122.00 | $366K | 106,221 |
| 2025-12-15 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −3,000 | $122.00 | $366K | 153,503 |
| 2025-12-10 | Mercier Johanna Chief Commercial Officer | Option exercise | +3,842 | 111,035 | ||
| 2025-12-10 | Mercier Johanna Chief Commercial Officer | Shares withheld for taxes | −1,814 | $121.34 | $220K | 109,221 |
| 2025-12-10 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −3,842 | 27,674 | ||
| 2025-12-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +10,426 | 581,629 | ||
| 2025-12-10 | O'Day Daniel Patrick Chairman & CEO | Shares withheld for taxes | −4,931 | $121.34 | $598K | 576,698 |
| 2025-12-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −10,426 | 88,070 | ||
| 2025-12-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +3,693 | 158,248 | ||
| 2025-12-10 | Dickinson Andrew D Chief Financial Officer | Shares withheld for taxes | −1,745 | $121.34 | $212K | 156,503 |
| 2025-12-10 | Dickinson Andrew D Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,693 | 27,526 | ||
| 2025-11-28 | Bluestone Jeffrey Director | Option exercise | +5,000 | $64.92 | $325K | 13,920 |
| 2025-11-28 | Bluestone Jeffrey Director | Sale | −5,000 | $125.08 | $625K | 8,920 |
| 2025-11-28 | Bluestone Jeffrey Director | Option exercise · Non-qualified Stock Option (Right to Buy) | −5,000 | 7,648 | ||
| 2025-11-28 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −3,212 | $125.91 | $404K | 577,991 |
| 2025-11-28 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −6,788 | $126.84 | $861K | 571,203 |
Page 11 of 30 · 599 trades